Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-10-21

Clinical Trial Update: EPIC US Pivotal Study [NA]

View source ↗

Summary

EPIC US pivotal study evaluating carotid artery intervention by Lumen Biomedical has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lumen Biomedical | Conditions: Percutaneous Intervention of the Carotid Arteries. | NA | Status: COMPLETED